Filing Details
- Accession Number:
- 0001179110-12-006531
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-04-05 13:00:00
- Reporting Period:
- 2012-04-03
- Filing Date:
- 2012-04-05
- Accepted Time:
- 2012-04-05 16:23:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1274792 | Merrimack Pharmaceuticals Inc | MACK | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1368753 | J Anthony Sinskey | C/O Merrimack Pharmaceuticals, Inc. One Kendall Square, Suite B7201 Cambridge MA 02139 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-04-03 | 7,142 | $7.00 | 326,309 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2012-04-03 | 36,723 | $0.00 | 363,032 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2012-04-03 | 18,024 | $0.00 | 381,056 | No | 4 | C | Indirect | By Wife |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | C | Direct | |
| No | 4 | C | Indirect | By Wife |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series B Convertible Preferred Stock | Disposition | 2012-04-03 | 23,793 | $0.00 | 36,723 | $0.00 |
| Common Stock | Series C Convertible Preferred Stock | Disposition | 2012-04-03 | 18,024 | $0.00 | 18,024 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Indirect |
Footnotes
- Each share of Series B Convertible Preferred Stock automatically converted into approximately 1.5435 shares of Common Stock upon the closing of the issuer's initial public offering and had no expiration date.
- Each share of Series C Convertible Preferred Stock automatically converted into one share of Common Stock upon the closing of the issuer's initial public offering and had no expiration date.
Billionaire Hedge Funds
